The expression of this “pseudomutant” phenotype may explain how some cancers develop despite the retention of WT p53 and suggest that some plasticity with respect to WT and mutant p53 activity may be highly beneficial during tumorigenesis. The gene discussed is TP53; the disease is cancer.